Company intelligence / Profile preview

Colibri Heart Valve

Broomfield, Colorado, United Statescolibrihv.com ↗

Ownership: Private
Development stage: Clinical

Overview

The Colibri TAVI System has demonstrated favorable early clinical results in feasibility and pilot studies. Initial post-procedure outcomes show low aortic valve pressure gradients, no paravalvular leakage or insufficiency, and large effective orifice area. The system’s ready-to-use design enables rapid deployment and may reduce procedural errors. As of late 2023, the device remains investigational and not yet commercially available in the US or EU.

Therapeutic areas: Cardiovascular
Modalities: DeviceBiologic (porcine tissue valve bioprosthesis)
Industry: Implantable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Colibri Heart Valve.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colibri Heart Valve.

Explore the full profile